AstraZeneca's Ambitious $15 Billion Investment Strategy in China Drives Global Attention
British pharmaceutical powerhouse AstraZeneca has unveiled an aggressive plan focused on pumping $15 billion into China's economic landscape across the following seven years. This groundbreaking investment initiative centers on enlarging.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
